Search Results - "Rubio Terres, C."
-
1
Economic impact of managing invasive mold disease with isavuconazole compared with liposomal amphotericin B followed by posaconazole in Spain
Published in Expert review of anti-infective therapy (02-08-2024)“…Invasive fungal infections (IFI) are associated with significant morbidity and mortality. The objective of this work was to compare the costs per adult…”
Get more information
Journal Article -
2
Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study
Published in Clinical microbiology and infection (01-06-2010)“…The aim of this study was to determine the impact on healthcare resource utilization and associated costs of bacteraemia due to methicillin-resistant…”
Get full text
Journal Article -
3
Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain
Published in European journal of clinical microbiology & infectious diseases (01-11-2015)“…The objective of this paper was to assess the cost–utility of fidaxomicin versus vancomycin in the treatment of Clostridium difficile infection (CDI) in three…”
Get full text
Journal Article -
4
Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain
Published in Expert review of pharmacoeconomics & outcomes research (03-05-2020)“…To estimate the cost-effectiveness of Cladribine Tablets in the treatment of relapsing multiple sclerosis (RMS) with high disease activity compared with…”
Get more information
Journal Article -
5
Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients
Published in ClinicoEconomics and outcomes research (01-01-2015)“…To estimate the cost-effectiveness of three echinocandins (anidulafungin, caspofungin, and micafungin) and generic fluconazole in the treatment of…”
Get full text
Journal Article -
6
Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism
Published in Applied health economics and health policy (01-04-2015)“…Background Patients with venous thromboembolism (VTE) commonly have an underlying genetic predisposition. However, genetic tests nowadays in use have very low…”
Get full text
Journal Article -
7
Economic Evaluation of Cardio inCode®, a Clinical-Genetic Function for Coronary Heart Disease Risk Assessment
Published in Applied health economics and health policy (01-10-2013)“…Background A clinical–genetic function (Cardio inCode ® ) was generated using genetic variants associated with coronary heart disease (CHD), but not with…”
Get full text
Journal Article -
8
Cost-Effectiveness Analysis of the Treatment of Ventilator-Associated Pneumonia with Linezolid or Vancomycin in Spain
Published in Journal of chemotherapy (Florence) (01-04-2005)“…The aim of this study was to assess the cost-effectiveness of linezolid (LIN) versus vancomycin (VAN) for the treatment of ventilator-associated pneumonia…”
Get full text
Journal Article -
9
-
10
Cost-utility analysis of relapsing-remitting multiple sclerosis treatment with azathioprine or interferon beta in Spain
Published in Revista de neurologiá (16-06-2005)“…To carry out a cost-utility analysis of the treatment of relapsing-remitting multiple sclerosis (RRMS) with azathioprine (Imurel) or beta interferon (all,…”
Get full text
Journal Article -
11
Cost-effectiveness of venlafaxine for the treatment of depression and anxiety. Bibliographic review
Published in Actas españolas de psiquiatría (01-05-2006)“…To compare the efficiency of the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD) with venlafaxine in comparison with…”
Get more information
Journal Article -
12
Cost-Effectiveness of Enoxaparin as Thromboprophylaxis in Acutely Ill Medical Patients in Spain
Published in Value in health (01-03-2003)“…The objective of this study was to determine the cost-effectiveness of thromboprophylaxis with enoxaparin versus no thromboprophylaxis in patients with acute…”
Get full text
Journal Article -
13
-
14
Burden of diabetes mellitus in patients with acromegaly treated with second-line pharmacotherapy in Spain
Published in ClinicoEconomics and outcomes research (01-07-2019)“…To evaluate the burden of diabetes mellitus (DM) in adult patients with acromegaly treated with second-line pharmacotherapy, from the perspective of the…”
Get full text
Journal Article -
15
PND63 - COST-EFFECTIVENESS OF CLADRIBINE TABLETS AND FINGOLIMOD IN THE TREATMENT OF REMITTING MULTIPLE SCLEROSIS WITH HIGH DISEASE ACTIVITY IN SPAIN
Published in Value in health (01-10-2018)Get full text
Journal Article -
16
Cost-Effectiveness Analysis of Apixaban Versus Rivaroxaban for Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation in Spain
Published in Value in health (01-11-2013)Get full text
Journal Article -
17
Cost-Effectiveness Analysis of Apixaban Versus Dabigatran for Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation in Spain
Published in Value in health (01-11-2013)Get full text
Journal Article -
18
Economic Analysis Of Thrombo Incode, A Clinical-Genetic Function For Assessing The Risk Of Venous Thromboembolism
Published in Value in health (01-11-2014)Get full text
Journal Article -
19
-
20